Role of hedgehog signaling pathway in NASH

International Journal of Molecular Sciences

Volumn 17, Issue 6, 2016, Pages

  Machado, Mariana Verdelho ^a,b   Diehl, Anna Mae ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Hedgehog pathway; Nonalcoholic fatty liver disease; Wound healing response

Indexed keywords

SONIC HEDGEHOG PROTEIN;

CHRONIC LIVER DISEASE; GENE EXPRESSION; HUMAN; INFLAMMATION; LIPOTOXICITY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PALMITOYLATION; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; SCAR FORMATION; SIGNAL TRANSDUCTION; STEATOSIS; TISSUE REPAIR; UPREGULATION; WOUND HEALING; ANIMAL; DISEASE MODEL; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HEDGEHOG PROTEINS; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84971556267     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17060857     Document Type: Review

References (84)

1. Loomba, R., Sanyal, A.J. The global nafld epidemic. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 686-690. [CrossRef] [PubMed]
2. Lonardo, A., Bellentani, S., Argo, C.K., Ballestri, S., Byrne, C.D., Caldwell, S.H., Cortez-Pinto, H., Grieco, A., Machado, M.V., Miele, L., et al. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Dig. Liver Dis. 2015, 47, 997-1006. [CrossRef] [PubMed]
3. Machado, M.V., Diehl, A.M. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 2006, 40, S17-S29. [CrossRef] [PubMed]
4. Machado, M.V., Cortez-Pinto, H. Non-alcoholic fatty liver disease: What the clinician needs to know. World J. Gastroenterol. 2014, 20, 12956-12980. [CrossRef] [PubMed]
5. Wong, R.J., Aguilar, M., Cheung, R., Perumpail, R.B., Harrison, S.A., Younossi, Z.M., Ahmed, A. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the united states. Gastroenterology 2015, 148, 547-555. [CrossRef] [PubMed]
6. Wong, R.J., Cheung, R., Ahmed, A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 2014, 59, 2188-2195. [CrossRef] [PubMed]
7. Angulo, P., Kleiner, D.E., Dam-Larsen, S., Adams, L.A., Bjornsson, E.S., Charatcharoenwitthaya, P., Mills, P.R., Keach, J.C., Lafferty, H.D., Stahler, A., et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015, 149, 389-397.e10. [CrossRef] [PubMed]
8. Ekstedt, M., Hagstrom, H., Nasr, P., Fredrikson, M., Stal, P., Kechagias, S., Hultcrantz, R. Fibrosis stage is the strongest predictor for disease-specific mortality in nafld after up to 33 years of follow-up. Hepatology 2015, 61, 1547-1554. [CrossRef] [PubMed]
9. Singh, S., Allen, A.M., Wang, Z., Prokop, L.J., Murad, M.H., Loomba, R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies. Clin. Gastroenterol. Hepatol. 2015, 13, 643-654, e641-649; quiz e639-640. [CrossRef] [PubMed]
10. Moylan, C.A., Pang, H., Dellinger, A., Suzuki, A., Garrett, M.E., Guy, C.D., Murphy, S.K., Ashley-Koch, A.E., Choi, S.S., Michelotti, G.A., et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 2014, 59, 471-482. [CrossRef] [PubMed]
11. Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomcik, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis. Arthritis Rheum. 2012, 64, 2724-2733. [CrossRef] [PubMed]
12. Kugler, M.C., Joyner, A.L., Loomis, C.A., Munger, J.S. Sonic hedgehog signaling in the lung. From development to disease. Am. J. Respir. Cell Mol. Biol. 2015, 52, 1-13. [CrossRef] [PubMed]
13. Fabian, S.L., Penchev, R.R., St-Jacques, B., Rao, A.N., Sipila, P., West, K.A., McMahon, A.P., Humphreys, B.D. Hedgehog-gli pathway activation during kidney fibrosis. Am. J. Pathol. 2012, 180, 1441-1453. [CrossRef] [PubMed]
14. Wang, L.W., Lin, H., Lu, Y., Xia, W., Gao, J., Li, Z.S. Sonic hedgehog expression in a rat model of chronic pancreatitis. World J. Gastroenterol. 2014, 20, 4712-4717. [CrossRef] [PubMed]
15. Choi, S.S., Omenetti, A., Syn, W.K., Diehl, A.M. The role of hedgehog signaling in fibrogenic liver repair. Int. J. Biochem. Cell Biol. 2011, 43, 238-244. [CrossRef] [PubMed]
16. Nusslein-Volhard, C., Wieschaus, E. Mutations affecting segment number and polarity in drosophila. Nature 1980, 287, 795-801. [CrossRef] [PubMed]
17. Briscoe, J., Therond, P.P. The mechanisms of hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell Biol. 2013, 14, 416-429. [CrossRef] [PubMed]
18. Farzan, S.F., Singh, S., Schilling, N.S., Robbins, D.J. The adventures of sonic hedgehog in development and repair. III. Hedgehog processing and biological activity. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G844-G849. [CrossRef] [PubMed]
19. Pathi, S., Pagan-Westphal, S., Baker, D.P., Garber, E.A., Rayhorn, P., Bumcrot, D., Tabin, C.J., Blake Pepinsky, R., Williams, K.P. Comparative biological responses to human sonic, indian, and desert hedgehog. Mech. Dev. 2001, 106, 107-117. [CrossRef]
20. Merchant, J.L., Saqui-Salces, M. Inhibition of hedgehog signaling in the gastrointestinal tract: Targeting the cancer microenvironment. Cancer Treat. Rev. 2014, 40, 12-21. [CrossRef] [PubMed]
21. Hu, L., Lin, X., Lu, H., Chen, B., Bai, Y. An overview of hedgehog signaling in fibrosis. Mol. Pharmacol. 2015, 87, 174-182. [CrossRef] [PubMed]
22. Teperino, R., Aberger, F., Esterbauer, H., Riobo, N., Pospisilik, J.A. Canonical and non-canonical hedgehog signalling and the control of metabolism. Semin. Cell Dev. Biol. 2014, 33, 81-92. [CrossRef] [PubMed]
23. Jia, J., Kolterud, A., Zeng, H., Hoover, A., Teglund, S., Toftgard, R., Liu, A. Suppressor of fused inhibits mammalian hedgehog signaling in the absence of cilia. Dev. Biol. 2009, 330, 452-460. [CrossRef] [PubMed]
24. Ikram, M.S., Neill, G.W., Regl, G., Eichberger, T., Frischauf, A.M., Aberger, F., Quinn, A., Philpott, M. Gli2 is expressed in normal human epidermis and bcc and induces Gli1 expression by binding to its promoter. J. Investig. Dermatol. 2004, 122, 1503-1509. [CrossRef] [PubMed]
25. Pan, Y., Bai, C.B., Joyner, A.L., Wang, B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol. Cell. Biol. 2006, 26, 3365-3377. [CrossRef] [PubMed]
26. Roy, S. Cilia and hedgehog: When and how was their marriage solemnized? Differentiation 2012, 83, S43-S48. [CrossRef] [PubMed]
27. Peterson, K.A., Nishi, Y., Ma, W., Vedenko, A., Shokri, L., Zhang, X., McFarlane, M., Baizabal, J.M., Junker, J.P., van Oudenaarden, A., et al. Neural-specific Sox2 input and differential Gli-binding affinity provide context and positional information in Shh-directed neural patterning. Genes Dev. 2012, 26, 2802-2816. [CrossRef] [PubMed]
28. Chinchilla, P., Xiao, L., Kazanietz, M.G., Riobo, N.A. Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways. Cell Cycle 2010, 9, 570-579. [CrossRef] [PubMed]
29. Pasca di Magliano, M., Hebrok, M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 2003, 3, 903-911. [CrossRef] [PubMed]
30. Barnes, E.A., Kong, M., Ollendorff, V., Donoghue, D.J. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 2001, 20, 2214-2223. [CrossRef] [PubMed]
31. Polizio, A.H., Chinchilla, P., Chen, X., Manning, D.R., Riobo, N.A. Sonic hedgehog activates the gtpases rac1 and rhoa in a Gli-independent manner through coupling of smoothened to Gi proteins. Sci. Signal. 2011, 4 Pt 7. [CrossRef] [PubMed]
32. Teperino, R., Amann, S., Bayer, M., McGee, S.L., Loipetzberger, A., Connor, T., Jaeger, C., Kammerer, B., Winter, L., Wiche, G., et al. Hedgehog partial agonism drives warburg-like metabolism in muscle and brown fat. Cell 2012, 151, 414-426. [CrossRef] [PubMed]
33. Bijlsma, M.F., Borensztajn, K.S., Roelink, H., Peppelenbosch, M.P., Spek, C.A. Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites. Cell Signal. 2007, 19, 2596-2604. [CrossRef] [PubMed]
34. Polizio, A.H., Chinchilla, P., Chen, X., Kim, S., Manning, D.R., Riobo, N.A. Heterotrimeric Gi proteins link hedgehog signaling to activation of rho small gtpases to promote fibroblast migration. J. Biol. Chem. 2011, 286, 19589-19596. [CrossRef] [PubMed]
35. Razumilava, N., Gradilone, S.A., Smoot, R.L., Mertens, J.C., Bronk, S.F., Sirica, A.E., Gores, G.J. Non-canonical hedgehog signaling contributes to chemotaxis in cholangiocarcinoma. J. Hepatol. 2014, 60, 599-605. [CrossRef] [PubMed]
36. Das, S., Samant, R.S., Shevde, L.A. Nonclassical activation of hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to smoothened-targeting hedgehog inhibition. J. Biol. Chem. 2013, 288, 11824-11833. [CrossRef] [PubMed]
37. Michelotti, G.A., Xie, G., Swiderska, M., Choi, S.S., Karaca, G., Kruger, L., Premont, R., Yang, L., Syn, W.K., Metzger, D., et al. Smoothened is a master regulator of adult liver repair. J. Clin. Investig. 2013, 123, 2380-2394. [CrossRef] [PubMed]
38. Sommerfeld, A., Reinehr, R., Haussinger, D. Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis. J. Biol. Chem. 2015, 290, 4398-4409. [CrossRef] [PubMed]
39. Mooney, C.J., Hakimjavadi, R., Fitzpatrick, E., Kennedy, E., Walls, D., Morrow, D., Redmond, E.M., Cahill, P.A. Hedgehog and resident vascular stem cell fate. Stem Cells Int. 2015, 2015, 468428. [CrossRef] [PubMed]
40. Sicklick, J.K., Li, Y.X., Melhem, A., Schmelzer, E., Zdanowicz, M., Huang, J., Caballero, M., Fair, J.H., Ludlow, J.W., McClelland, R.E., et al. Hedgehog signalingmaintains resident hepatic progenitors throughout life. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G859-G870. [CrossRef] [PubMed]
41. Jung, Y., Witek, R.P., Syn, W. K., Choi, S.S., Omenetti, A., Premont, R., Guy, C.D., Diehl, A.M. Signals from dying hepatocytes trigger growth of liver progenitors. Gut 2010, 59, 655-665. [CrossRef] [PubMed]
42. Fleig, S.V., Choi, S.S., Yang, L., Jung, Y., Omenetti, A., VanDongen, H.M., Huang, J., Sicklick, J.K., Diehl, A.M. Hepatic accumulation of hedgehog-reactive progenitors increases with severity of fatty liver damage in mice. Lab. Investig. 2007, 87, 1227-1239. [CrossRef] [PubMed]
43. Jung, Y., Brown, K.D., Witek, R.P., Omenetti, A., Yang, L., Vandongen, M., Milton, R.J., Hines, I.N., Rippe, R.A., Spahr, L., et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 2008, 134, 1532-1543. [CrossRef] [PubMed]
44. Hirose, Y., Itoh, T., Miyajima, A. Hedgehog signal activation coordinates proliferation and differentiation of fetal liver progenitor cells. Exp. Cell Res. 2009, 315, 2648-2657. [CrossRef] [PubMed]
45. Syn, W.K., Witek, R.P., Curbishley, S.M., Jung, Y., Choi, S.S., Enrich, B., Omenetti, A., Agboola, K.M., Fearing, C.M., Tilg, H., et al. Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur. J. Immunol. 2009, 39, 1879-1892. [CrossRef] [PubMed]
46. Pereira, T.A., Xie, G., Choi, S.S., Syn, W.K., Voieta, I., Lu, J., Chan, I.S., Swiderska, M., Amaral, K.B., Antunes, C.M., et al. Macrophage-derived hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni. Liver Int. 2013, 33, 149-161. [CrossRef] [PubMed]
47. Iwaisako, K., Brenner, D.A., Kisseleva, T. What’s new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J. Gastroenterol. Hepatol. 2012, 27 (Suppl. 2), 65-68. [CrossRef] [PubMed]
48. Swiderska-Syn, M., Syn, W.K., Xie, G., Kruger, L., Machado, M.V., Karaca, G., Michelotti, G.A., Choi, S.S., Premont, R.T., Diehl, A.M. Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut 2013. [CrossRef] [PubMed]
49. Yang, L., Wang, Y., Mao, H., Fleig, S., Omenetti, A., Brown, K.D., Sicklick, J.K., Li, Y.X., Diehl, A.M. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J. Hepatol. 2008, 48, 98-106. [CrossRef] [PubMed]
50. Xie, G., Choi, S.S., Syn, W. K., Michelotti, G.A., Swiderska, M., Karaca, G., Chan, I.S., Chen, Y., Diehl, A.M. Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation. Gut 2013, 62, 299-309. [CrossRef] [PubMed]
51. Guy, C.D., Suzuki, A., Zdanowicz, M., Abdelmalek, M.F., Burchette, J., Unalp, A., Diehl, A.M., Nash, C.R.N. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 2012, 55, 1711-1721. [CrossRef] [PubMed]
52. Rangwala, F., Guy, C.D., Lu, J., Suzuki, A., Burchette, J.L., Abdelmalek, M.F., Chen, W., Diehl, A.M. Increased production of sonic hedgehog by ballooned hepatocytes. J. Pathol. 2011, 224, 401-410. [CrossRef] [PubMed]
53. Machado, M.V., Michelotti, G.A., Pereira Tde, A., Boursier, J., Kruger, L., Swiderska-Syn, M., Karaca, G., Xie, G., Guy, C.D., Bohinc, B., et al. Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut 2015, 64, 1148-1157. [CrossRef] [PubMed]
54. Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y., Choi, S.S., Witek, R.P., Alpini, G., Venter, J., Vandongen, H.M., et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J. Clin. Investig. 2008, 118, 3331-3342. [CrossRef] [PubMed]
55. Sicklick, J.K., Li, Y.X., Choi, S.S., Qi, Y., Chen, W., Bustamante, M., Huang, J., Zdanowicz, M., Camp, T., Torbenson, M.S., et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab. Investig. 2005, 85, 1368-1380. [CrossRef] [PubMed]
56. Lin, N., Tang, Z., Deng, M., Zhong, Y., Lin, J., Yang, X., Xiang, P., Xu, R. Hedgehog-mediated paracrine interaction between hepatic stellate cells and marrow-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2008, 372, 260-265. [CrossRef] [PubMed]
57. Kramann, R., Schneider, R.K., DiRocco, D.P., Machado, F., Fleig, S., Bondzie, P.A., Henderson, J.M., Ebert, B.L., Humphreys, B.D. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015, 16, 51-66. [CrossRef] [PubMed]
58. Peng, T., Frank, D.B., Kadzik, R.S., Morley, M.P., Rathi, K.S., Wang, T., Zhou, S., Cheng, L., Lu, M.M., Morrisey, E.E. Hedgehog actively maintains adult lung quiescence and regulates repair and regeneration. Nature 2015, 526, 578-582. [CrossRef] [PubMed]
59. Omenetti, A., Popov, Y., Jung, Y., Choi, S.S., Witek, R.P., Yang, L., Brown, K.D., Schuppan, D., Diehl, A.M. The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. Gut 2008, 57, 1275-1282. [CrossRef] [PubMed]
60. Omenetti, A., Syn, W.K., Jung, Y., Francis, H., Porrello, A., Witek, R.P., Choi, S.S., Yang, L., Mayo, M.J., Gershwin, M.E., et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 2009, 50, 518-527. [CrossRef] [PubMed]
61. Syn, W. K., Jung, Y., Omenetti, A., Abdelmalek, M., Guy, C.D., Yang, L., Wang, J., Witek, R.P., Fearing, C.M., Pereira, T.A., et al. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 2009, 137, 1478-1488.e8. [CrossRef] [PubMed]
62. Syn, W.K., Oo, Y.H., Pereira, T.A., Karaca, G.F., Jung, Y., Omenetti, A., Witek, R.P., Choi, S.S., Guy, C.D., Fearing, C.M., et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 2010, 51, 1998-2007. [CrossRef] [PubMed]
63. Syn, W.K., Choi, S.S., Liaskou, E., Karaca, G.F., Agboola, K.M., Oo, Y.H., Mi, Z., Pereira, T.A., Zdanowicz, M., Malladi, P., et al. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 2011, 53, 106-115. [CrossRef] [PubMed]
64. Pazzaglia, S., Cifaldi, L., Saran, A., Nobili, V., Fruci, D., Alisi, A. Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma. Hepatology 2012, 56, 1589. [CrossRef] [PubMed]
65. Machado, M.V., Michelotti, G.A., Xie, G., Almeida Pereira, T., Boursier, J., Bohnic, B., Guy, C.D., Diehl, A.M. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS ONE 2015, 10, e0127991. [CrossRef] [PubMed]
66. Kakisaka, K., Cazanave, S.C., Werneburg, N.W., Razumilava, N., Mertens, J.C., Bronk, S.F., Gores, G.J. A hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes. J. Hepatol. 2012, 57, 844-851. [CrossRef] [PubMed]
67. Nakashima, H., Nakamura, M., Yamaguchi, H., Yamanaka, N., Akiyoshi, T., Koga, K., Yamaguchi, K., Tsuneyoshi, M., Tanaka, M., Katano, M. Nuclear factor-kappab contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res. 2006, 66, 7041-7049. [CrossRef] [PubMed]
68. Syn, W.K., Agboola, K.M., Swiderska, M., Michelotti, G.A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I.S., Karaca, G.F., et al. Nkt-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 2012, 61, 1323-1329. [CrossRef] [PubMed]
69. Kwon, H., Song, K., Han, C., Chen, W., Wang, Y., Dash, S., Lim, K., Wu, T. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology 2015. [CrossRef] [PubMed]
70. Chung, S.I., Moon, H., Ju, H.L., Cho, K.J., Kim, D.Y., Han, K.H., Eun, J.W., Nam, S.W., Ribback, S., Dombrowski, F., et al. Hepatic expression of sonic hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model. J. Hepatol. 2015, 64, 618-627. [CrossRef] [PubMed]
71. Hirsova, P., Ibrahim, S.H., Bronk, S.F., Yagita, H., Gores, G.J. Vismodegib suppresses trail-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS ONE 2013, 8, e70599. [CrossRef] [PubMed]
72. Machado, M.V., Michelotti, G.A., Pereira, T.A., Xie, G., Premont, R., Cortez-Pinto, H., Diehl, A.M. Accumulation of duct cells with activated yap parallels fibrosis progression in non-alcoholic fatty liver disease. J. Hepatol. 2015, 63, 962-970. [CrossRef] [PubMed]
73. Richardson, M.M., Jonsson, J.R., Powell, E.E., Brunt, E.M., Neuschwander-Tetri, B.A., Bhathal, P.S., Dixon, J.B., Weltman, M.D., Tilg, H., Moschen, A.R., et al. Progressive fibrosis in nonalcoholic steatohepatitis: Association with altered regeneration and a ductular reaction. Gastroenterology 2007, 133, 80-90. [CrossRef] [PubMed]
74. Ye, F., Jing, Y.Y., Guo, S.W., Yu, G.F., Fan, Q.M., Qu, F.F., Gao, L., Yang, Y., Wu, D., Meng, Y., et al. Proliferative ductular reactions correlate with hepatic progenitor cell and predict recurrence in hcc patients after curative resection. Cell Biosci. 2014, 4, 50. [CrossRef] [PubMed]
75. Swiderska-Syn, M., Suzuki, A., Guy, C.D., Schwimmer, J.B., Abdelmalek, M.F., Lavine, J.E., Diehl, A.M. Hedgehog pathway and pediatric nonalcoholic fatty liver disease. Hepatology 2013, 57, 1814-1825. [CrossRef] [PubMed]
76. Omenetti, A., Bass, L.M., Anders, R.A., Clemente, M.G., Francis, H., Guy, C.D., McCall, S., Choi, S.S., Alpini, G., Schwarz, K.B., et al. Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology 2011, 53, 1246-1258. [CrossRef] [PubMed]
77. Guy, C.D., Suzuki, A., Abdelmalek, M.F., Burchette, J.L., Diehl, A.M., NASH CRN. Treatment response in the pivens trial is associated with decreased hedgehog pathway activity. Hepatology 2015, 61, 98-107. [CrossRef] [PubMed]
78. Grzelak, C.A., Martelotto, L.G., Sigglekow, N.D., Patkunanathan, B., Ajami, K., Calabro, S.R., Dwyer, B.J., Tirnitz-Parker, J.E., Watkins, D.N., Warner, F.J., et al. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. J. Hepatol. 2014, 60, 143-151. [CrossRef] [PubMed]
79. Matz-Soja, M., Gebhardt, R. The many faces of hedgehog signalling in the liver: Recent progress reveals striking cellular diversity and the importance of microenvironments. J. Hepatol. 2014, 61, 1449-1450. [CrossRef] [PubMed]
80. Uschner, F.E., Ranabhat, G., Choi, S.S., Granzow, M., Klein, S., Schierwagen, R., Raskopf, E., Gautsch, S., van der Ven, P.F., Furst, D.O., et al. Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension. Sci. Rep. 2015, 5, 14573. [CrossRef] [PubMed]
81. Corbit, K.C., Aanstad, P., Singla, V., Norman, A.R., Stainier, D.Y., Reiter, J.F. Vertebrate smoothened functions at the primary cilium. Nature 2005, 437, 1018-1021. [CrossRef] [PubMed]
82. Ochoa, B., Syn, W.K., Delgado, I., Karaca, G.F., Jung, Y., Wang, J., Zubiaga, A.M., Fresnedo, O., Omenetti, A., Zdanowicz, M., et al. Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. Hepatology 2010, 51, 1712-1723. [CrossRef] [PubMed]
83. Lim, Y.C., McGlashan, S.R., Cooling, M.T., Long, D.S. Culture and detection of primary cilia in endothelial cell models. Cilia 2015, 4, 11. [CrossRef] [PubMed]
84. Guha, M. Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential. Nat. Rev. Drug Discov. 2012, 11, 257-258. [CrossRef] [PubMed]